Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations.

Autor: Davidson B; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310, Oslo, Norway. bend@medisin.uio.no.; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, N-0316, Oslo, Norway. bend@medisin.uio.no., Holth A; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310, Oslo, Norway., Lindemann K; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, N-0316, Oslo, Norway.; Department of Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310, Oslo, Norway., Zahl Eriksson AG; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, N-0316, Oslo, Norway.; Department of Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310, Oslo, Norway., Nilsen TA; Department of Tumor Biology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310, Oslo, Norway., Torgunrud A; Department of Tumor Biology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310, Oslo, Norway.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Dec; Vol. 485 (6), pp. 1053-1061. Date of Electronic Publication: 2024 May 11.

Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium.

Autor: Rios-Doria E; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nobre SP; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sassine D; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glaser G; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA., Eriksson AG; Department of Gynecologic Oncology, Division of Cancer Medicine, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ataseven B; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; Bielefeld University, Medical School and University Medical Center OWL, Klinikum Lippe, Department of Gynecology, Gynecologic Oncology and Obstetrics, Detmold, Germany., du Bois A; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Alektiar K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leitao MM Jr; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of OB/GYN, Weill Cornell Medical College, New York, NY, USA., Abu-Rustum NR; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of OB/GYN, Weill Cornell Medical College, New York, NY, USA., Mueller JJ; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of OB/GYN, Weill Cornell Medical College, New York, NY, USA. Electronic address: muellerj@mskcc.org.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Nov; Vol. 190, pp. 236-242. Date of Electronic Publication: 2024 Sep 07.

2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.

Autor: Rios-Doria E; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA., Abu-Rustum NR; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA., Glaser G; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA., McGree M; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Eriksson AG; Department of Gynecologic Oncology, Norwegian Radium Hospital, Oslo, Norway.; Faculty of Clinical Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Pham M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Soliman P; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ataseven B; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynecology, Gynecologic Oncology and Obstetrics, Bielefeld University, Medical School and University Medical Center OWL, Klinikum Lippe, Detmold, Germany., Alektiar K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Zamarin D; Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Leitao ML Jr; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA., Mueller J; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA muellerj@mskcc.org.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Oct 07; Vol. 34 (10), pp. 1580-1587. Date of Electronic Publication: 2024 Oct 07.

European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management.

Autor: Fotopoulou C; Gynecologic oncology, Hammersmith Hospital, London, UK chfotopoulou@gmail.com., Eriksson AG; Department of Gynecologic Oncology, Norwegian Radium Hospital, Oslo, Norway.; The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Planchamp F; Institut Bergonie, Bordeaux, France., Morice P; Surgery, Gustave Roussy, Villejuif, Île-de-France, France.; Paris-South University/Paris Saclay, Paris, Île-de-France, France., Taylor A; Gynaecology Oncology, Royal Marsden Hospital, London, UK., Sturdza A; Department of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Vienna, Austria., Florin Coza O; Iuliu Hagieganu University of Medicine and Pharmacy Faculty of Medicine, Cluj Napoca, Romania.; Oncology Institute 'Prof. Dr.I.Chiricuta', Cluj Napoca, Romania., Halaska MJ; Dept. of Obstetrics and Gynaecology, 3rd Medical Faculty, Charles University, Prague, Czech Republic., Martinelli F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Armbrust R; Dept. of Gynecology, Charite University Hospital Berlin, Berlin, Germany., Chargari C; Hôpital Universitaire Pitié Salpêtrière, Paris, Île-de-France, France.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Apr 01; Vol. 34 (4), pp. 480-489. Date of Electronic Publication: 2024 Apr 01.

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Autor: Ledermann JA; Department of Oncology, UCL Cancer Institute, University College London, London, UK. Electronic address: clinicalguidelines@esmo.org., Matias-Guiu X; CIBERONC, Madrid; Department of Pathology, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, University of Lleida, Lleida; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain. Electronic address: admin@esp-pathology.org., Amant F; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands., Concin N; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria; Department of Gynaecology and Gynaecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany., Davidson B; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Fotopoulou C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., González-Martin A; Department of Medical Oncology and Program in Solid Tumours-Cima, Cancer Center Clínica Universidad de Navarra, Madrid, Spain., Gourley C; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Leary A; Department of Medicine, Institut Gustave Roussy, Villejuif, France., Lorusso D; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy., Banerjee S; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., Chiva L; Department of Gynaecology and Obstetrics, Cancer Center Clínica Universidad de Navarra, Navarra, Spain., Cibula D; Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Colombo N; Department of Gynecologic Oncology, Istituto Europeo di Oncologia IRCCS, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Croce S; Department of Biopathology, Bergonié Institut, Bordeaux, France., Eriksson AG; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Falandry C; Institute of Aging, Hospices Civils de Lyon, Lyon; CarMeN Laboratory, INSERM U1060/Université Lyon 1/INRAE U1397/Hospices Civils Lyon, Pierre-Bénite, France., Fischerova D; Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Harter P; Department of Gynaecology and Gynaecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany., Joly F; GINECO Group, Department of Medical Oncology, Centre François-Baclesse, University of Caen Normandy, Caen, France., Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain., Lok C; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands., Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich., Marmé F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Germany; Department of Obstetrics and Gynecology, University Hospital Mannheim, Mannheim; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Marth C; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria., McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK., McNeish IA; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Morice P; Department of Gynecologic Surgery, Gustave Roussy Cancer Campus, Villejuif, France., Nicum S; Department of Oncology, UCL Cancer Institute, University College London, London, UK., Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona., Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario - INCLIVA, CIBERONC, Valencia, Spain., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori di Napoli, IRCCS Fondazione Pascale, Napoli, Italy., Ramirez PT; Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, USA., Ray-Coquard I; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard, Lyon, France., Romero I; Department of Medical Oncology, Instituto Valenciano Oncologia, Valencia, Spain., Scambia G; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy., Sehouli J; North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin; Department of Gynecology with Center for Oncological Surgery, Charité Berlin University of Medicine, Berlin, Germany., Shapira-Frommer R; Sheba Medical Center, Ramat Gan, Israel., Sundar S; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham; Pan Birmingham Gynaecological Cancer Centre, City Hospital, Birmingham, UK., Tan DSP; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; National University of Singapore (NUS) Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer Science Institute, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore, Singapore., Taskiran C; Department of Gynecologic Oncology, School of Medicine, Koç University, Istanbul, Turkey., van Driel WJ; Department of Gynecology, Center for Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands., Vergote I; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Planchamp F; Institut Bergonié, Bordeaux, France., Sessa C; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland., Fagotti A; Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Department of Woman, Child and Public Health, Catholic University of Sacred Heart, Rome, Italy. Electronic address: guidelines@esgo.org.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 248-266. Date of Electronic Publication: 2024 Feb 01.